Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 10/20 | 0.39 |
| ▸ | SLC6A15 | Q9H2J7 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 2/20 | 0.33 |
| ▸ | PLG | P00747 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.32 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7958636 | 0.81 | ERN1 (0.43) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL9382711 | 0.80 | LMNA (0.39) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL7956038 | 0.78 | LMNA (0.37) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL597800 | 0.74 | LMNA (0.45) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL10548337 | 0.74 | LMNA (0.40) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL5196825 | 0.73 | LMNA (0.41) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL9191402 | 0.72 | LMNA (0.42) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL8924794 | 0.72 | LMNA (0.42) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL9383271 | 0.72 | ERN1 (0.49) | LMNAMAPK1RAB9AERN1SLC6A15 | |
| SCHEMBL7962633 | 0.72 | LMNA (0.35) | LMNAMAPK1RAB9AERN1SLC6A15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | LMNA 3240/4885MAPK1 2316/4885RAB9A 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.